BD Reports First Quarter Fiscal 2024 Financial Results : vimarsana.com

Margin Execution Drives Better Performance in Quarter and Higher Guidance for Fiscal 2024
Q1 revenue of $4.7 billion increased 2.6% as reported, 1.6% currency-neutral and 2.4% organicQ1 GAAP and...

Related Keywords

United States , Ukraine , Kenya , China , Russia , Kenyan , Troy Kirkpatrick , Tom Polen , Research Instruments , Bd Life Sciences , World Economic Forum Zero Health Gaps Pledge , Catheter Solutions , Diagnostics Solutions , European Union Medical Device Regulation , Medication Delivery Solutions , Exchange Commission , Medication Management Solutions , Linkedin , Clinical Solutions , Fillable Solutions , Margin Execution Drives Better Performance , Higher Guidance , Integrated Diagnostics Solutions , Capillary Blood Collection System , Kenyan Government , World Economic Forum , Zero Health Gaps Pledge , Quarter Fiscal , Diluted Earnings , Pharmaceutical Systems , Vascular Access Management , Infusion System , Pharmacy Automation , Pre Fillable Solutions , Integrated Diagnostic Solutions , Clinical Reagents , Clinical Cell Analyzer , Sample Preparation System , Peripheral Intervention , Critical Care , Advanced Repair , Infection Prevention , Surgical Instrumentation , Peripheral Vascular Disease , Venous Stent System , Full Year Fiscal , Devices Regulations , Middle East , Adam Reiffe , Investor Relations , Public Relations , Months Ended December , Diabetes Care , Foreign Currency , Revenue Growth , Share Percentage , Markets ,